Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study.
Kristine Højgaard AllinCamilla B JensenRikke K JacobsenTine JessPublished in: Journal of gastroenterology (2022)
In this population-based study, we report that despite anti-inflammatory effects and a notable impact on the gut microbiome, metformin use is not associated with reduced risk of older onset IBD.